CARCINOEMBRYONIC ANTIGEN INCREASED

This adverse event was reported 1939 times

These drugs are most commonly taken by patients reporting CARCINOEMBRYONIC ANTIGEN INCREASED:

# Drug Count
0 CAPECITABINE 201
1 LETROZOLE 171
2 BEVACIZUMAB 159
3 OXALIPLATIN 155
4 RIBOCICLIB 150
5 FULVESTRANT 134
6 LETROZOLE TABLETS 130
7 FLUOROURACIL 123
8 FLUOROURACIL CREAM, 0.5% 123
9 REGORAFENIB 101
See all common drugs associated with CARCINOEMBRYONIC ANTIGEN INCREASED

CARCINOEMBRYONIC ANTIGEN INCREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DACOMITINIB 26 0.0347
1 PENICILLAMINE 10 0.0108
2 AMIVANTAMAB AND HYALURONIDASE-LPUJ (HUMAN RECOMBINANT) 3 0.0098
3 REGORAFENIB 101 0.0087
4 BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, AND TETRACYCLINE HYDROCHLORIDE 8 0.0071
5 PANITUMUMAB 100 0.0062
6 DATOPOTAMAB DERUXTECAN 5 0.0058
7 VANDETANIB 9 0.0050
8 TRIFLURIDINE AND TIPIRACIL 50 0.0046
9 ZOLBETUXIMAB 7 0.0046
See all drugs enriched for association with CARCINOEMBRYONIC ANTIGEN INCREASED